Kenta Yagi

780 total citations
62 papers, 519 citations indexed

About

Kenta Yagi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pharmacology. According to data from OpenAlex, Kenta Yagi has authored 62 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 7 papers in Pharmacology. Recurrent topics in Kenta Yagi's work include Lung Cancer Treatments and Mutations (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Biomedical Ethics and Regulation (4 papers). Kenta Yagi is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Biomedical Ethics and Regulation (4 papers). Kenta Yagi collaborates with scholars based in Japan and Taiwan. Kenta Yagi's co-authors include Mitsuhiro Goda, Keisuke Ishizawa, Yoshito Zamami, Minoru Morimatsu, Yasuyuki Sasaguri, Takahiro Niimura, Masayuki Chuma, Hirofumi Hamano, Masaaki Sunamoto and Tomoaki Doi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Kenta Yagi

54 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenta Yagi Japan 13 148 116 95 48 42 62 519
Arash Ghasemi Iran 14 115 0.8× 94 0.8× 58 0.6× 42 0.9× 21 0.5× 38 502
Marija Popović Canada 12 83 0.6× 87 0.8× 65 0.7× 33 0.7× 34 0.8× 45 601
Hao Ruan China 13 183 1.2× 122 1.1× 87 0.9× 35 0.7× 29 0.7× 19 456
Francesca Montalto Italy 10 254 1.7× 62 0.5× 111 1.2× 39 0.8× 52 1.2× 15 569
Siyu Li China 11 106 0.7× 113 1.0× 82 0.9× 28 0.6× 26 0.6× 41 326
Takeshi Kotake Japan 15 104 0.7× 106 0.9× 123 1.3× 50 1.0× 23 0.5× 59 461
Zhaolin Sun China 15 193 1.3× 83 0.7× 69 0.7× 54 1.1× 16 0.4× 51 550
Aleksandra Topić Serbia 13 135 0.9× 48 0.4× 77 0.8× 83 1.7× 44 1.0× 42 559
Yoon Jeong Nam South Korea 12 101 0.7× 90 0.8× 83 0.9× 66 1.4× 16 0.4× 38 381

Countries citing papers authored by Kenta Yagi

Since Specialization
Citations

This map shows the geographic impact of Kenta Yagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenta Yagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenta Yagi more than expected).

Fields of papers citing papers by Kenta Yagi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenta Yagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenta Yagi. The network helps show where Kenta Yagi may publish in the future.

Co-authorship network of co-authors of Kenta Yagi

This figure shows the co-authorship network connecting the top 25 collaborators of Kenta Yagi. A scholar is included among the top collaborators of Kenta Yagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenta Yagi. Kenta Yagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aizawa, Fuka, Hidetaka Kosako, SEIICHI TANIDA, et al.. (2025). Ursodeoxycholic acid alleviates multiple sclerosis via TGR5-dependent microglial regulation in mice. European Journal of Pharmacology. 1003. 177941–177941. 1 indexed citations
2.
Niimura, Takahiro, Mitsuhiro Goda, Kei Kawada, et al.. (2025). Cardiovascular Toxicity Profile of Macrolides Investigated Using VigiBase Data: A Pharmacovigilance Study. Cardiovascular Toxicology. 25(3). 498–506.
3.
Yagi, Kenta. (2025). Exploration of New Treatment Methods by Using Data Science. YAKUGAKU ZASSHI. 145(11). 895–898.
4.
Kawada, Kei, Takahiro Niimura, Hitoshi Fukuda, et al.. (2025). Risk factors for clazosentan-induced fluid retention in subarachnoid hemorrhage from the Japanese adverse event database. Journal of Stroke and Cerebrovascular Diseases. 34(6). 108296–108296. 1 indexed citations
5.
Miyata, Kôji, Yuki Izawa‐Ishizawa, Masateru Kondo, et al.. (2024). Unveiling the association between fluoroquinolones and aortic diseases using real-world database analysis and pharmacological experiments. Biomedicine & Pharmacotherapy. 179. 117418–117418. 1 indexed citations
6.
Aizawa, Fuka, Hirofumi Hamano, Naoto Okada, et al.. (2024). Assessing the effects of interprofessional education by hospital pharmacists on pharmaceutical students using a self-evaluation scale. Journal of Pharmaceutical Health Care and Sciences. 10(1). 61–61.
7.
Iida, Midori, Kenta Yagi, Mitsuhiro Goda, et al.. (2024). A network-based trans-omics approach for predicting synergistic drug combinations. SHILAP Revista de lepidopterología. 4(1). 154–154. 7 indexed citations
8.
Kawada, Kei, Tomoaki Ishida, Hitoshi Fukuda, et al.. (2024). Effects of renin-angiotensin system inhibitor and beta-blocker use on mortality in older patients with heart failure with reduced ejection fraction in Japan. Frontiers in Cardiovascular Medicine. 11. 1377228–1377228. 1 indexed citations
9.
Niimura, Takahiro, Mitsuhiro Goda, Kôji Miyata, et al.. (2023). Evaluation of cardiovascular toxicity of the atezolizumab and bevacizumab combination. SHILAP Revista de lepidopterología. 3. 1213771–1213771. 2 indexed citations
10.
Goda, Mitsuhiro, Yuki Izawa‐Ishizawa, Kenta Yagi, et al.. (2023). Valproic acid treatment attenuates cisplatin‐induced kidney injury by suppressing proximal tubular cell damage. Clinical and Translational Science. 16(11). 2369–2381. 4 indexed citations
11.
Yagi, Kenta, Fuka Aizawa, Soichiro Ushio, et al.. (2023). Effects of vonoprazan and proton pump inhibitors on the efficacy of bevacizumab: a multicentre retrospective study. Clinical and Experimental Medicine. 23(6). 2799–2804. 4 indexed citations
12.
Hamano, Hirofumi, Takahiro Niimura, Kenta Yagi, et al.. (2023). Structural characterization of the optical isomers esomeprazole and omeprazole using the JADER and FAERS databases. Toxicology and Applied Pharmacology. 475. 116632–116632. 4 indexed citations
13.
Niimura, Takahiro, Kôji Miyata, Hirofumi Hamano, et al.. (2023). Cardiovascular Toxicities Associated with Anaplastic Lymphoma Kinase Inhibitors: A Disproportionality Analysis of the WHO Pharmacovigilance Database (VigiBase). Drug Safety. 46(6). 545–552. 6 indexed citations
14.
Chuma, Masayuki, Takahiro Niimura, Yutaka Kondo, et al.. (2022). Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality Analysis. Clinical Infectious Diseases. 75(8). 1416–1422. 21 indexed citations
15.
Goda, Mitsuhiro, Kôji Miyata, Fuka Aizawa, et al.. (2022). Discovery of preventive drugs for cisplatin‐induced acute kidney injury using big data analysis. Clinical and Translational Science. 15(7). 1664–1675. 5 indexed citations
16.
Zamami, Yoshito, Takahiro Niimura, Takehiro Kawashiri, et al.. (2022). Identification of prophylactic drugs for oxaliplatin-induced peripheral neuropathy using big data. Biomedicine & Pharmacotherapy. 148. 112744–112744. 14 indexed citations
17.
Sakaguchi, Satoshi, et al.. (2021). Research Ethics Consultation in Nursing Studies. Journal of Empirical Research on Human Research Ethics. 17(1-2). 63–69. 2 indexed citations
18.
Zamami, Yoshito, Hirofumi Hamano, Takahiro Niimura, et al.. (2021). Drug-Repositioning Approaches Based on Medical and Life Science Databases. Frontiers in Pharmacology. 12. 752174–752174. 12 indexed citations
19.
Yagi, Kenta, Kazuki Maeda, Satoshi Sakaguchi, et al.. (2020). Status of Institutional Review Board Meetings Conducted Through Web Conference Systems in Japanese National University Hospitals During the COVID-19 Pandemic: Questionnaire Study. Journal of Medical Internet Research. 22(11). e22302–e22302. 1 indexed citations
20.
Yagi, Kenta, Akira Shimada, & Toshiaki Sendo. (2018). Pharmacological inhibition of JAK3 enhances the antitumor activity of imatinib in human chronic myeloid leukemia. European Journal of Pharmacology. 825. 28–33. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arash Ghasemi Breakdown of academic impact, for papers by Marija Popović Breakdown of academic impact, for papers by Hao Ruan Breakdown of academic impact, for papers by Francesca Montalto Breakdown of academic impact, for papers by Siyu Li Breakdown of academic impact, for papers by Takeshi Kotake Breakdown of academic impact, for papers by Zhaolin Sun Breakdown of academic impact, for papers by Aleksandra Topić Breakdown of academic impact, for papers by Yoon Jeong Nam
Rankless by CCL
2026